You are here
Leukemia Insights: Vol. 16, No. 1 Spring 2011
New Strategies for Chronic Myelogenous Leukemia
Despite the major advances in therapy with the successes of imatinib and second-generation tyrosine kinase inhibitors, there is room for improving the management of patients with chronic myelogenous leukemia. Presently, there are clinical trials addressing the different stages of CML. Some of the available clinical trials are reviewed here.
Presently, there are clinical trials addressing the different stages of CML. Some of the available clinical trials are reviewed here.